What changed in Natera, Inc.'s latest annual report
In the year ended 31 Dec 2025, Natera, Inc.'s revenue rose 35.9% to USD 2.31bn, from USD 1.70bn; total liabilities rose 47.4% to USD 685.93m, from USD 465.31m; total assets rose 44.4% to USD 2.40bn, from USD 1.66bn.
Year ended 31 Dec 2025. Source: 10-K filed 27 Feb 2026, read it on SEC EDGAR.
USD 1.70bn to USD 2.31bn
The figures, year on year
| Item | Year before | Latest year | Change |
|---|---|---|---|
| Revenue | 1.70bn | 2.31bn | Up 35.9% |
| Net income | -190.43m | -208.16m | Not comparable |
| Total assets | 1.66bn | 2.40bn | Up 44.4% |
| Total liabilities | 465.31m | 685.93m | Up 47.4% |
| Shareholders' equity | 1.20bn | 1.71bn | Up 43.2% |
Questions people ask
Did Natera, Inc.'s revenue grow last year?
Revenue grew 35.9%, from USD 1.70bn to USD 2.31bn in the year ended 31 Dec 2025.
Is Natera, Inc. profitable?
Not in its latest year: it reported a net loss of USD 208.16m in the year ended 31 Dec 2025. The year before: a net loss of USD 190.43m.
Where do these numbers come from?
From Natera, Inc.'s own annual filings with the SEC. Each change is calculated from the reported figures; nothing is estimated.
Meeting a client who works with Natera, Inc.?
LYNORIQ remembers every client meeting the way this page tracks a filing: what changed since last time, what you promised, and what they owe you.
Start free See the demoOther Services-Medical Laboratories companies
- Labcorp Holdings Inc.Cash and cash equivalents down 65%
- Quest Diagnostics IncCash and cash equivalents down 23.5%
- Guardant Health, Inc.Total assets up 35.5%